Cavernotomes
Cavernotomes are specialized cutting-dilators that carve a channel through fibrotic corporal tissue during penile prosthesis implantation when standard blunt dilation fails. They are among the most-used tools in the prosthetic urologist's armamentarium for corporal fibrosis — employed in roughly 60% of fibrosis cases at tertiary referral centers.[1][2][3][4] Unlike the urethral sounds and bougies in this section, cavernotomes dilate the corpus cavernosum, not the urethra; they are grouped here as cutting-dilation instruments alongside the Otis urethrotome.
When They Are Needed
Cavernotomes are reached for when the corpus is too scarred to admit a cylinder by blunt dilation. The fibrosis most often follows:
- Prior prosthesis explant — for infection (~40%) or erosion (~17%)[4]
- Ischemic priapism (~33%), especially prolonged episodes or those treated with distal shunts[4][5]
- Other risk factors — prior radiation, cardiovascular/peripheral vascular disease, older age[6]
The full intraoperative escalation ladder (VED prehab → Hegar dilation → cavernotomes → counter incisions → corporeal excavation → grafting) is laid out on the penile-prosthesis revision-scenarios page.
Designs
Carrión-Rossello cavernotomes (first generation)
The original specialized corporal-excavation instruments, a historical milestone in prosthetic surgery. They were developed in the lineage of Hernán Carrión — co-developer of the landmark Small-Carrión malleable prosthesis (1975) and a foundational figure in penile prosthetics.[7] They are listed alongside the Otis urethrotome as early instruments for excavating fibrotic corpora, sharing the defining limitation of all cavernotomes: they work beneath the tunica albuginea, out of direct sight.[8]
Two drawbacks drove the development of the successor design: they required more extensive corporeal resection and longer operative times than the controlled-cut Mooreville-Wilson instruments.[1] The original publication predates indexed databases, so granular specifications and series data are not well captured in the searchable literature; in contemporary practice the generic term "cavernotomes" usually refers to the Mooreville-Wilson design.[3][9]
Mooreville-Wilson cavernotomes (Uramix) — the modern workhorse
Introduced in 1999 by Mooreville, Adrian, Delk, and Steven K. Wilson, this is the most widely used cavernotome set and is distributed commercially as the Uramix cavernotomes. "Mooreville-Wilson cavernotomes," "Mooreville Uramix cavernotomes," and "cutting cavernotomes" are used interchangeably in the literature.[1][3]
| Feature | Specification |
|---|---|
| Set | 5 graduated instruments |
| Diameters | 6–13 mm |
| Cut depth | controlled 1 mm cuts per pass — incremental, not bulk resection |
| Advancement | oscillating / rotational drilling, never forceful pushing |
| Extra function | can shave severely stenotic areas to develop a cavity |
| Cutting-edge orientation | always lateral, away from the urethra |
The 1 mm controlled cut is the key advance: it carves a channel without extensive resection and, in the original series, without any grafting to close the corporotomy — both of which the Carrión-Rossello era often required.[1]
Technique
- High transverse scrotal incision for access (the approach used across the original series).[1]
- Try blunt dilators first — Hegar dilators and/or Dilamezinsert; escalate to cavernotomes only when significant resistance is met.[5]
- Sequential upsizing — begin with the smallest (6 mm) and advance incrementally to larger diameters.[1]
- Oscillating advancement — rotate the instrument back and forth as it advances; controlled tissue removal, not a forceful thrust.[1]
- Keep the cutting edge lateral, away from the urethra, throughout — the cardinal safety rule.[5]
- Dilate distally and proximally from the corporotomy. In the Clavijo instructional video, dilation reached 11 Fr distally and 13 Fr proximally.[5]
Where no developable plane exists, the Wilson backward-cutting scissors are used first to carve the initial channel so a cavernotome can be seated.
Outcomes
In the original Mooreville-Wilson series (n = 16): 100% successful three-piece implantation, with 14/16 (87.5%) receiving downsized cylinders, 100% prosthesis survival at publication, no urethral lacerations, and no grafting required.[1]
In the largest multicenter series (Krughoff, n = 42): cavernotomes were used in 25/42 (59.5%) (one more needing limited sharp excision alongside), narrow cylinders in 23.8%, with a major complication rate of only 2.4% (one explant for infection/erosion). Sharp corporal excision beyond cavernotome use was rarely needed.[4]
Complications and Limitations
The defining limitation is blind instrumentation beneath the tunica albuginea.[8] In the original series this produced:
- Proximal crural perforation — 5/16 (31%), managed by suturing the rear-tip extender to the tunica with nonabsorbable suture[1]
- Distal tunical perforation — 4/16 (25%), repaired with native tissue[1]
- No urethral lacerations occurred, but the risk is intrinsic to the technique[1]
Direct-Vision Adjuncts and Alternatives
Several techniques address the "out of sight" problem or substitute for cavernotomes entirely:
- Ultrasound-guided cavernotomy (Shaeer 2007) — real-time sonography keeps the instrument in the mid-corpus, away from the tunica and urethra; reported operative time 50–60 min with no complications.[8]
- Corporoscopic excavation (Shaeer's technique) — optical urethrotomy plus transurethral resection instruments perform force-free, directly visualized excavation of scar through a ~1.5 cm tunical incision.[10]
- Corporeal excavation (Montague-Angermeier) — extended ventral corporotomies via an inverted-T penoscrotal incision develop a plane between scar and inner tunica for core removal of nearly all fibrotic tissue; successful in all 9 patients in the original series without grafting.[11]
- Downsized / narrow-base cylinders — narrow-diameter devices (e.g., Coloplast Titan Narrow Base) are used in ~24% of fibrosis cases when dilation is suboptimal.[4][5]
Tissue-Sparing Consideration
Aggressive coring is not always the right answer. A meta-analysis of 4 randomized studies (193 patients) found that cavernous tissue-sparing dilation — preserving the cavernosal artery and residual erectile tissue rather than maximally dilating — gave significantly higher cavernosal-artery preservation, residual tumescence in 87–89% vs 7–15%, and greater girth gains (+0.55–1.81 cm), without increasing complications.[12] The implication: the dilation strategy, including how aggressively cavernotomes are used, should be tailored to the severity of fibrosis rather than applied uniformly.
Place in Practice
No validated algorithm for corporal fibrosis exists, given limited comparative data; the choice among standard dilators, cavernotomes, corporeal excavation, and endoscopic approaches turns on surgeon experience and the corpus encountered.[3] The weight of evidence is reassuring: most patients can be implanted with standard dilators or cavernotomes alone, with sharp excision and grafting rarely required.[4] Complex cases belong with high-volume implanters.[6][13]
See also: Wilson Backward-Cutting Scissors, Hegar Dilators, Otis Urethrotome, Penile prosthesis revision scenarios — corporal fibrosis.
Videos
References
1. Mooreville M, Adrian S, Delk JR, Wilson SK. "Implantation of inflatable penile prosthesis in patients with severe corporeal fibrosis: introduction of a new penile cavernotome." J Urol. 1999;162(6):2054–7. doi:10.1016/S0022-5347(05)68099-8
2. Martínez-Salamanca JI, Mueller A, Moncada I, Carballido J, Mulhall JP. "Penile prosthesis surgery in patients with corporal fibrosis: a state of the art review." J Sex Med. 2011;8(7):1880–9. doi:10.1111/j.1743-6109.2011.02281.x
3. Trost L, Patil M, Kramer A. "Critical appraisal and review of management strategies for severe fibrosis during penile implant surgery." J Sex Med. 2015;12(Suppl 7):439–47. doi:10.1111/jsm.12985
4. Krughoff K, Bearelly P, Apoj M, et al. "Multicenter surgical outcomes of penile prosthesis placement in patients with corporal fibrosis and review of the literature." Int J Impot Res. 2022;34(1):86–92. doi:10.1038/s41443-020-00373-9
5. Clavijo RI, Sávio LF, Prakash NS, et al. "Three-piece penile prosthesis implantation in refractory ischemic priapism — tips and tricks." Urology. 2017;106:233–235. doi:10.1016/j.urology.2017.04.032
6. Chang C, Barham DW, Dalimov Z, et al. "New findings regarding predictors of poor corporal integrity in penile implant recipients: a multicenter international investigation." BJU Int. 2025;135(3):528–534. doi:10.1111/bju.16607
7. Martinez DR, Terlecki R, Brant WO. "The evolution and utility of the Small-Carrion prosthesis, its impact, and progression to the modern-day malleable penile prosthesis." J Sex Med. 2015;12(Suppl 7):423–30. doi:10.1111/jsm.13014
8. Shaeer O. "Penile prosthesis implantation in cases of fibrosis: ultrasound-guided cavernotomy and sheathed trochar excavation." J Sex Med. 2007;4(3):809–814. doi:10.1111/j.1743-6109.2007.00467.x
9. Wilson SK, Delk JR. "Historical advances in penile prostheses." Int J Impot Res. 2000;12(Suppl 4):S101–7. doi:10.1038/sj.ijir.3900586
10. Shaeer O, Shaeer A. "Corporoscopic excavation of the fibrosed corpora cavernosa for penile prosthesis implantation: optical corporotomy and trans-corporeal resection, Shaeer's technique." J Sex Med. 2007;4(1):218–225. doi:10.1111/j.1743-6109.2006.00348.x
11. Montague DK, Angermeier KW. "Corporeal excavation: new technique for penile prosthesis implantation in men with severe corporeal fibrosis." Urology. 2006;67(5):1072–5. doi:10.1016/j.urology.2005.11.001
12. Mohamed H, Abdelshafi A, Ahmed A, et al. "Impact of cavernous tissue-sparing techniques on postoperative outcomes in penile prosthesis surgery: a systematic review and meta-analysis." J Sex Med. 2026;23(2):qdag006. doi:10.1093/jsxmed/qdag006
13. Schifano N, Capogrosso P, Cakir OO, Dehò F, Garaffa G. "Surgical tips in difficult penile prosthetic surgery: a narrative review." Int J Impot Res. 2023;35(8):690–698. doi:10.1038/s41443-022-00629-6